Cancer Biomarkers Market to 2027 - Global Analysis and Forecasts By Biomarker Type (Genetic Biomarkers, Protein Biomarkers and Other Cancer Biomarkers), Profiling Technology (Omics Technologies, Imaging Technologies, Immunoassays, Cytogenetics, and Bioinformatics), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Leukemia, Bladder Cancer, and Other Cancer Types), Application (Diagnostics, Research and Development, Prognostics, and Other Applications), and Geography
Report Code: TIPBT00002663 No. of Pages: 150 Category: Biotechnology Status: Upcoming
Cancer biomarkers are the molecules that help in the diagnosis as well as the treatment of various forms of cancer. These molecules are produced by the cancer tissue or by other cells in the body in response to cancer. These molecules can be monitored by obtaining samples such as, blood, stool, urine, tumor tissue, or other tissues or bodily fluids.
Rise in the number of cancer cases as well as increasing research and development activities is anticipated to drive the growth of the cancer biomarkers market. Rising awareness regarding personalized medicine is expected to offer significant growth opportunities in the market in the coming years.
The "Global Cancer biomarkers Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product, application, end user, and geography. The global cancer biomarkers market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global cancer biomarkers market is segmented on the basis of biomarker type, profiling technology, cancer type, and application. on the basis of biomarker type, the cancer biomarkers market is segmented as, genetic biomarkers, protein biomarkers and other cancer biomarkers. The segment of genetic biomarkers is further classified as, leukemia, lung cancer, breast cancer, and prostate cancer. On the basis of profiling technology, the market is segmented as, omics technologies, imaging technologies, immunoassays, cytogenetics, and bioinformatics.
The omics technologies is further categorized as, proteomics and genomics. Imaging technologies are classified as, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and mammography. The cancer biomarkers market is classified based on cancer types such as, breast cancer, lung cancer, prostate cancer, leukemia, bladder cancer, and other cancer types. On the basis of application, the market is segmented as, diagnostics, research and development, prognostics, and other applications.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cancer biomarkers market based on biomarker type, profiling technology, cancer type, and application. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cancer biomarkers market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the cancer biomarkers market in the coming years, owing to rising incidence of cancer. Asia Pacific is expected to witness significant growth during the forecast period, due to increase in the number of R&D activities being conducted in the field of cancer therapy.
The report analyzes factors affecting cancer biomarkers market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cancer biomarkers market in these regions.
The report also includes the profiles of key cancer biomarkers manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the cancer biomarkers market include, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., QIAGEN, Illumina, Inc., GENERAL ELECTRIC COMPANY, bioMérieux, Inc., Creative Diagnostics, Hologic Inc., and Quest Diagnostics among others.
Rise in the number of cancer cases as well as increasing research and development activities is anticipated to drive the growth of the cancer biomarkers market. Rising awareness regarding personalized medicine is expected to offer significant growth opportunities in the market in the coming years.
The "Global Cancer biomarkers Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product, application, end user, and geography. The global cancer biomarkers market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global cancer biomarkers market is segmented on the basis of biomarker type, profiling technology, cancer type, and application. on the basis of biomarker type, the cancer biomarkers market is segmented as, genetic biomarkers, protein biomarkers and other cancer biomarkers. The segment of genetic biomarkers is further classified as, leukemia, lung cancer, breast cancer, and prostate cancer. On the basis of profiling technology, the market is segmented as, omics technologies, imaging technologies, immunoassays, cytogenetics, and bioinformatics.
The omics technologies is further categorized as, proteomics and genomics. Imaging technologies are classified as, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and mammography. The cancer biomarkers market is classified based on cancer types such as, breast cancer, lung cancer, prostate cancer, leukemia, bladder cancer, and other cancer types. On the basis of application, the market is segmented as, diagnostics, research and development, prognostics, and other applications.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cancer biomarkers market based on biomarker type, profiling technology, cancer type, and application. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cancer biomarkers market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the cancer biomarkers market in the coming years, owing to rising incidence of cancer. Asia Pacific is expected to witness significant growth during the forecast period, due to increase in the number of R&D activities being conducted in the field of cancer therapy.
The report analyzes factors affecting cancer biomarkers market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cancer biomarkers market in these regions.
The report also includes the profiles of key cancer biomarkers manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the cancer biomarkers market include, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., QIAGEN, Illumina, Inc., GENERAL ELECTRIC COMPANY, bioMérieux, Inc., Creative Diagnostics, Hologic Inc., and Quest Diagnostics among others.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. CANCER BIOMARKERS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Cancer Biomarkers Market - By Biomarker Type
3.2.2. Cancer Biomarkers Market - By Profiling Technology
3.2.3. Cancer Biomarkers Market - By Cancer Type
3.2.4. Cancer Biomarkers Market - By Application
3.2.5. Cancer Biomarkers Market - By Region
3.2.5.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. CANCER BIOMARKERS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. CANCER BIOMARKERS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL CANCER BIOMARKERS MARKET OVERVIEW
5.2. GLOBAL CANCER BIOMARKERS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS
6. CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - BY BIOMARKER TYPE
6.1. OVERVIEW
6.2. BIOMARKER TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. GENETIC BIOMARKERS MARKET
6.3.1. Overview
6.3.2. Genetic Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3. Leukemia Market
6.3.3.1. Overview
6.3.3.2. Leukemia Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4. Lung Cancer Market
6.3.4.1. Overview
6.3.4.2. Lung Cancer Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5. Breast Cancer Market
6.3.5.1. Overview
6.3.5.2. Breast Cancer Market Revenue Forecasts and Analysis (US$ Mn)
6.3.6. Prostate Cancer Market
6.3.6.1. Overview
6.3.6.2. Prostate Cancer Market Revenue Forecasts and Analysis (US$ Mn)
6.4. PROTEIN BIOMARKERS MARKET
6.4.1. Overview
6.4.2. Protein Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.5. OTHER CANCER BIOMARKERS MARKET
6.5.1. Overview
6.5.2. Other Cancer Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
7. CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - BY PROFILING TECHNOLOGY
7.1. OVERVIEW
7.2. PROFILING TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. OMICS TECHNOLOGIES MARKET
7.3.1. Overview
7.3.2. Omics Technologies Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3. Proteomics Market
7.3.3.1. Overview
7.3.3.2. Proteomics Market Revenue Forecasts and Analysis (US$ Mn)
7.3.4. Genomics Market
7.3.4.1. Overview
7.3.4.2. Genomics Market Revenue Forecasts and Analysis (US$ Mn)
7.4. IMAGING TECHNOLOGIES MARKET
7.4.1. Overview
7.4.2. Imaging Technologies Market Revenue Forecasts and Analysis (US$ Mn)
7.4.3. Ultrasound Market
7.4.3.1. Overview
7.4.3.2. Ultrasound Market Revenue Forecasts and Analysis (US$ Mn)
7.4.4. Computed Tomography (CT) Market
7.4.4.1. Overview
7.4.4.2. Computed Tomography (CT) Market Revenue Forecasts and Analysis (US$ Mn)
7.4.5. Magnetic Resonance Imaging (MRI) Market
7.4.5.1. Overview
7.4.5.2. Magnetic Resonance Imaging (MRI) Market Revenue Forecasts and Analysis (US$ Mn)
7.4.6. Positron Emission Tomography (PET) Market
7.4.6.1. Overview
7.4.6.2. Positron Emission Tomography (PET) Market Revenue Forecasts and Analysis (US$ Mn)
7.5. IMMUNOASSAYS MARKET
7.5.1. Overview
7.5.2. Immunoassays Market Revenue Forecasts and Analysis (US$ Mn)
7.6. CYTOGENETICS MARKET
7.6.1. Overview
7.6.2. Cytogenetics Market Revenue Forecasts and Analysis (US$ Mn)
7.7. BIOINFORMATICS MARKET
7.7.1. Overview
7.7.2. Bioinformatics Market Revenue Forecasts and Analysis (US$ Mn)
8. CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - BY CANCER TYPE
8.1. OVERVIEW
8.2. CANCER TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. BREAST CANCER MARKET
8.3.1. Overview
8.3.2. Breast Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.4. LUNG CANCER MARKET
8.4.1. Overview
8.4.2. Lung Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.5. PROSTATE CANCER MARKET
8.5.1. Overview
8.5.2. Prostate Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.6. LEUKEMIA MARKET
8.6.1. Overview
8.6.2. Leukemia Market Revenue Forecasts and Analysis (US$ Mn)
8.7. BLADDER CANCER MARKET
8.7.1. Overview
8.7.2. Bladder Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.8. OTHER CANCER TYPES MARKET
8.8.1. Overview
8.8.2. Other Cancer Types Market Revenue Forecasts and Analysis (US$ Mn)
9. CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. DIAGNOSTICS MARKET
9.3.1. Overview
9.3.2. Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
9.4. RESEARCH AND DEVELOPMENT MARKET
9.4.1. Overview
9.4.2. Research and Development Market Revenue Forecasts and Analysis (US$ Mn)
9.5. PROGNOSTICS MARKET
9.5.1. Overview
9.5.2. Prognostics Market Revenue Forecasts and Analysis (US$ Mn)
9.6. OTHER APPLICATIONS MARKET
9.6.1. Overview
9.6.2. Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
10. NORTH AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. NORTH AMERICA CANCER BIOMARKERS MARKET OVERVIEW
10.2. NORTH AMERICA CANCER BIOMARKERS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. NORTH AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY BIOMARKER TYPE (US$ MN)
10.3.1. North America Genetic Biomarkers Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.4. NORTH AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY PROFILING TECHNOLOGY (US$ MN)
10.4.1. North America Omics Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.4.2. North America Imaging Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.5. NORTH AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY CANCER TYPE (US$ MN)
10.6. NORTH AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.7. NORTH AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.8. US MARKET OVERVIEW
10.8.1. US Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
10.8.1.1. US Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.2. US Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
10.8.2.1. US Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.2.2. US Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.3. US Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
10.8.4. US Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.9. CANADA MARKET OVERVIEW
10.9.1. Canada Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
10.9.1.1. Canada Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.9.2. Canada Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
10.9.2.1. Canada Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.9.2.2. Canada Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.9.3. Canada Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
10.9.4. Canada Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.10. MEXICO MARKET OVERVIEW
10.10.1. Mexico Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
10.10.1.1. Mexico Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.10.2. Mexico Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
10.10.2.1. Mexico Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.10.2.2. Mexico Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.10.3. Mexico Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
10.10.4. Mexico Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11. EUROPE CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. EUROPE CANCER BIOMARKERS MARKET OVERVIEW
11.2. EUROPE CANCER BIOMARKERS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. EUROPE CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY BIOMARKER TYPE (US$ MN)
11.3.1. Europe Genetic Biomarkers Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.4. EUROPE CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY PROFILING TECHNOLOGY (US$ MN)
11.4.1. Europe Omics Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.4.2. Europe Imaging Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.5. EUROPE CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY CANCER TYPE (US$ MN)
11.6. EUROPE CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.7. EUROPE CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.8. UK MARKET OVERVIEW
11.8.1. UK Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
11.8.1.1. UK Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.2. UK Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
11.8.2.1. UK Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.2.2. UK Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.3. UK Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
11.8.4. UK Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.9. GERMANY MARKET OVERVIEW
11.9.1. Germany Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
11.9.1.1. Germany Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.9.2. Germany Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
11.9.2.1. Germany Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.9.2.2. Germany Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.9.3. Germany Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
11.9.4. Germany Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.10. FRANCE MARKET OVERVIEW
11.10.1. France Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
11.10.1.1. France Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.10.2. France Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
11.10.2.1. France Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.10.2.2. France Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.10.3. France Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
11.10.4. France Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12. ASIA PACIFIC CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. ASIA PACIFIC CANCER BIOMARKERS MARKET OVERVIEW
12.2. ASIA PACIFIC CANCER BIOMARKERS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. ASIA PACIFIC CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY BIOMARKER TYPE (US$ MN)
12.3.1. Asia Pacific Genetic Biomarkers Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.4. ASIA PACIFIC CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY PROFILING TECHNOLOGY (US$ MN)
12.4.1. Asia Pacific Omics Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.4.2. Asia Pacific Imaging Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.5. ASIA PACIFIC CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY CANCER TYPE (US$ MN)
12.6. ASIA PACIFIC CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.7. ASIA PACIFIC CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.8. CHINA MARKET OVERVIEW
12.8.1. China Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
12.8.1.1. China Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.2. China Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
12.8.2.1. China Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.2.2. China Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.3. China Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
12.8.4. China Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.9. JAPAN MARKET OVERVIEW
12.9.1. Japan Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
12.9.1.1. Japan Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.9.2. Japan Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
12.9.2.1. Japan Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.9.2.2. Japan Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.9.3. Japan Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
12.9.4. Japan Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.10. INDIA MARKET OVERVIEW
12.10.1. India Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
12.10.1.1. India Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.10.2. India Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
12.10.2.1. India Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.10.2.2. India Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.10.3. India Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
12.10.4. India Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13. MIDDLE EAST AND AFRICA (MEA) CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. MIDDLE EAST & AFRICA (MEA) CANCER BIOMARKERS MARKET OVERVIEW
13.2. MIDDLE EAST & AFRICA (MEA) CANCER BIOMARKERS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. MIDDLE EAST & AFRICA (MEA) CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY BIOMARKER TYPE (US$ MN)
13.3.1. Middle East & Africa (MEA) Genetic Biomarkers Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.4. MIDDLE EAST & AFRICA (MEA) CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY PROFILING TECHNOLOGY (US$ MN)
13.4.1. Middle East & Africa (MEA) Omics Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.4.2. Middle East & Africa (MEA) Imaging Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.5. MIDDLE EAST & AFRICA (MEA) CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY CANCER TYPE (US$ MN)
13.6. MIDDLE EAST & AFRICA (MEA) CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.7. MIDDLE EAST & AFRICA (MEA) CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.8. SOUTH AFRICA MARKET OVERVIEW
13.8.1. South Africa Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
13.8.1.1. South Africa Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.8.2. South Africa Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
13.8.2.1. South Africa Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.8.2.2. South Africa Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.8.3. South Africa Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
13.8.4. South Africa Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
?
13.9. SAUDI ARABIA MARKET OVERVIEW
13.9.1. Saudi Arabia Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
13.9.1.1. Saudi Arabia Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.9.2. Saudi Arabia Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
13.9.2.1. Saudi Arabia Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.9.2.2. Saudi Arabia Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.9.3. Saudi Arabia Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
13.9.4. Saudi Arabia Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.10. UAE MARKET OVERVIEW
13.10.1. UAE Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
13.10.1.1. UAE Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.10.2. UAE Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
13.10.2.1. UAE Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.10.2.2. UAE Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.10.3. UAE Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
13.10.4. UAE Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
14. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
14.1. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET OVERVIEW
14.2. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
14.3. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY BIOMARKER TYPE (US$ MN)
14.3.1. South and Central America Genetic Biomarkers Market Revenue and Forecasts Analysis - By Type (US$ Mn)
14.4. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY PROFILING TECHNOLOGY (US$ MN)
14.4.1. South and Central America Omics Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
14.4.2. South and Central America Imaging Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
14.5. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY CANCER TYPE (US$ MN)
14.6. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
14.7. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
14.8. BRAZIL MARKET OVERVIEW
14.8.1. Brazil Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
14.8.1.1. Brazil Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
14.8.2. Brazil Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
14.8.2.1. Brazil Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
14.8.2.2. Brazil Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
14.8.3. Brazil Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
14.8.4. Brazil Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
15. INDUSTRY LANDSCAPE
15.1. ORGANIC GROWTH STRATEGIES
15.1.1. New Product Launches
15.1.2. Marketing & Promotional Activities
15.2. INORGANIC GROWTH STRATEGIES
15.2.1. Partnerships, Collaborations, and Joint Ventures
15.2.2. Mergers & Acquisitions
?
16. CANCER BIOMARKERS MARKET, KEY COMPANY PROFILES
16.1. THERMO FISHER SCIENTIFIC INC.
16.1.1. Key Facts
16.1.2. Business Description
16.1.3. Financial Overview
16.1.4. Product Portfolio
16.1.5. SWOT Analysis
16.1.6. Key Developments
16.2. HOFFMANN-LA ROCHE LTD
16.2.1. Key Facts
16.2.2. Business Description
16.2.3. Financial Overview
16.2.4. Product Portfolio
16.2.5. SWOT Analysis
16.2.6. Key Developments
16.3. BIO-RAD LABORATORIES, INC.
16.3.1. Key Facts
16.3.2. Business Description
16.3.3. Financial Overview
16.3.4. Product Portfolio
16.3.5. SWOT Analysis
16.3.6. Key Developments
16.4. QIAGEN
16.4.1. Key Facts
16.4.2. Business Description
16.4.3. Financial Overview
16.4.4. Product Portfolio
16.4.5. SWOT Analysis
16.4.6. Key Developments
16.5. ILLUMINA, INC.
16.5.1. Key Facts
16.5.2. Business Description
16.5.3. Financial Overview
16.5.4. Product Portfolio
16.5.5. SWOT Analysis
16.5.6. Key Developments
16.6. GENERAL ELECTRIC COMPANY
16.6.1. Business Description
16.6.2. Financial Overview
16.6.3. Product Portfolio
16.6.4. SWOT Analysis
16.6.5. Key Developments
16.7. BIOMÉRIEUX, INC.
16.7.1. Key Facts
16.7.2. Business Description
16.7.3. Financial Overview
16.7.4. Product Portfolio
16.7.5. SWOT Analysis
16.7.6. Key Developments
16.8. CREATIVE DIAGNOSTICS
16.8.1. Key Facts
16.8.2. Business Description
16.8.3. Financial Overview
16.8.4. Product Portfolio
16.8.5. SWOT Analysis
16.8.6. Key Developments
16.9. HOLOGIC INC.
16.9.1. Key Facts
16.9.2. Business Description
16.9.3. Financial Overview
16.9.4. Product Portfolio
16.9.5. SWOT Analysis
16.9.6. Key Developments
16.10. QUEST DIAGNOSTICS
16.10.1. Key Facts
16.10.2. Business Description
16.10.3. Financial Overview
16.10.4. Product Portfolio
16.10.5. SWOT Analysis
16.10.6. Key Developments
17. APPENDIX
17.1. ABOUT THE INSIGHT PARTNERS
17.2. GLOSSARY OF TERMS
17.3. RESEARCH METHODOLOGY
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. CANCER BIOMARKERS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Cancer Biomarkers Market - By Biomarker Type
3.2.2. Cancer Biomarkers Market - By Profiling Technology
3.2.3. Cancer Biomarkers Market - By Cancer Type
3.2.4. Cancer Biomarkers Market - By Application
3.2.5. Cancer Biomarkers Market - By Region
3.2.5.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. CANCER BIOMARKERS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. CANCER BIOMARKERS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL CANCER BIOMARKERS MARKET OVERVIEW
5.2. GLOBAL CANCER BIOMARKERS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS
6. CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - BY BIOMARKER TYPE
6.1. OVERVIEW
6.2. BIOMARKER TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. GENETIC BIOMARKERS MARKET
6.3.1. Overview
6.3.2. Genetic Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3. Leukemia Market
6.3.3.1. Overview
6.3.3.2. Leukemia Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4. Lung Cancer Market
6.3.4.1. Overview
6.3.4.2. Lung Cancer Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5. Breast Cancer Market
6.3.5.1. Overview
6.3.5.2. Breast Cancer Market Revenue Forecasts and Analysis (US$ Mn)
6.3.6. Prostate Cancer Market
6.3.6.1. Overview
6.3.6.2. Prostate Cancer Market Revenue Forecasts and Analysis (US$ Mn)
6.4. PROTEIN BIOMARKERS MARKET
6.4.1. Overview
6.4.2. Protein Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.5. OTHER CANCER BIOMARKERS MARKET
6.5.1. Overview
6.5.2. Other Cancer Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
7. CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - BY PROFILING TECHNOLOGY
7.1. OVERVIEW
7.2. PROFILING TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. OMICS TECHNOLOGIES MARKET
7.3.1. Overview
7.3.2. Omics Technologies Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3. Proteomics Market
7.3.3.1. Overview
7.3.3.2. Proteomics Market Revenue Forecasts and Analysis (US$ Mn)
7.3.4. Genomics Market
7.3.4.1. Overview
7.3.4.2. Genomics Market Revenue Forecasts and Analysis (US$ Mn)
7.4. IMAGING TECHNOLOGIES MARKET
7.4.1. Overview
7.4.2. Imaging Technologies Market Revenue Forecasts and Analysis (US$ Mn)
7.4.3. Ultrasound Market
7.4.3.1. Overview
7.4.3.2. Ultrasound Market Revenue Forecasts and Analysis (US$ Mn)
7.4.4. Computed Tomography (CT) Market
7.4.4.1. Overview
7.4.4.2. Computed Tomography (CT) Market Revenue Forecasts and Analysis (US$ Mn)
7.4.5. Magnetic Resonance Imaging (MRI) Market
7.4.5.1. Overview
7.4.5.2. Magnetic Resonance Imaging (MRI) Market Revenue Forecasts and Analysis (US$ Mn)
7.4.6. Positron Emission Tomography (PET) Market
7.4.6.1. Overview
7.4.6.2. Positron Emission Tomography (PET) Market Revenue Forecasts and Analysis (US$ Mn)
7.5. IMMUNOASSAYS MARKET
7.5.1. Overview
7.5.2. Immunoassays Market Revenue Forecasts and Analysis (US$ Mn)
7.6. CYTOGENETICS MARKET
7.6.1. Overview
7.6.2. Cytogenetics Market Revenue Forecasts and Analysis (US$ Mn)
7.7. BIOINFORMATICS MARKET
7.7.1. Overview
7.7.2. Bioinformatics Market Revenue Forecasts and Analysis (US$ Mn)
8. CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - BY CANCER TYPE
8.1. OVERVIEW
8.2. CANCER TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. BREAST CANCER MARKET
8.3.1. Overview
8.3.2. Breast Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.4. LUNG CANCER MARKET
8.4.1. Overview
8.4.2. Lung Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.5. PROSTATE CANCER MARKET
8.5.1. Overview
8.5.2. Prostate Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.6. LEUKEMIA MARKET
8.6.1. Overview
8.6.2. Leukemia Market Revenue Forecasts and Analysis (US$ Mn)
8.7. BLADDER CANCER MARKET
8.7.1. Overview
8.7.2. Bladder Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.8. OTHER CANCER TYPES MARKET
8.8.1. Overview
8.8.2. Other Cancer Types Market Revenue Forecasts and Analysis (US$ Mn)
9. CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. DIAGNOSTICS MARKET
9.3.1. Overview
9.3.2. Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
9.4. RESEARCH AND DEVELOPMENT MARKET
9.4.1. Overview
9.4.2. Research and Development Market Revenue Forecasts and Analysis (US$ Mn)
9.5. PROGNOSTICS MARKET
9.5.1. Overview
9.5.2. Prognostics Market Revenue Forecasts and Analysis (US$ Mn)
9.6. OTHER APPLICATIONS MARKET
9.6.1. Overview
9.6.2. Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
10. NORTH AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. NORTH AMERICA CANCER BIOMARKERS MARKET OVERVIEW
10.2. NORTH AMERICA CANCER BIOMARKERS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. NORTH AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY BIOMARKER TYPE (US$ MN)
10.3.1. North America Genetic Biomarkers Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.4. NORTH AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY PROFILING TECHNOLOGY (US$ MN)
10.4.1. North America Omics Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.4.2. North America Imaging Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.5. NORTH AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY CANCER TYPE (US$ MN)
10.6. NORTH AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.7. NORTH AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.8. US MARKET OVERVIEW
10.8.1. US Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
10.8.1.1. US Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.2. US Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
10.8.2.1. US Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.2.2. US Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.3. US Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
10.8.4. US Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.9. CANADA MARKET OVERVIEW
10.9.1. Canada Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
10.9.1.1. Canada Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.9.2. Canada Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
10.9.2.1. Canada Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.9.2.2. Canada Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.9.3. Canada Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
10.9.4. Canada Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.10. MEXICO MARKET OVERVIEW
10.10.1. Mexico Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
10.10.1.1. Mexico Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.10.2. Mexico Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
10.10.2.1. Mexico Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.10.2.2. Mexico Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.10.3. Mexico Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
10.10.4. Mexico Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11. EUROPE CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. EUROPE CANCER BIOMARKERS MARKET OVERVIEW
11.2. EUROPE CANCER BIOMARKERS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. EUROPE CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY BIOMARKER TYPE (US$ MN)
11.3.1. Europe Genetic Biomarkers Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.4. EUROPE CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY PROFILING TECHNOLOGY (US$ MN)
11.4.1. Europe Omics Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.4.2. Europe Imaging Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.5. EUROPE CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY CANCER TYPE (US$ MN)
11.6. EUROPE CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.7. EUROPE CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.8. UK MARKET OVERVIEW
11.8.1. UK Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
11.8.1.1. UK Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.2. UK Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
11.8.2.1. UK Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.2.2. UK Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.3. UK Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
11.8.4. UK Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.9. GERMANY MARKET OVERVIEW
11.9.1. Germany Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
11.9.1.1. Germany Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.9.2. Germany Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
11.9.2.1. Germany Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.9.2.2. Germany Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.9.3. Germany Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
11.9.4. Germany Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.10. FRANCE MARKET OVERVIEW
11.10.1. France Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
11.10.1.1. France Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.10.2. France Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
11.10.2.1. France Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.10.2.2. France Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.10.3. France Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
11.10.4. France Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12. ASIA PACIFIC CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. ASIA PACIFIC CANCER BIOMARKERS MARKET OVERVIEW
12.2. ASIA PACIFIC CANCER BIOMARKERS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. ASIA PACIFIC CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY BIOMARKER TYPE (US$ MN)
12.3.1. Asia Pacific Genetic Biomarkers Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.4. ASIA PACIFIC CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY PROFILING TECHNOLOGY (US$ MN)
12.4.1. Asia Pacific Omics Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.4.2. Asia Pacific Imaging Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.5. ASIA PACIFIC CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY CANCER TYPE (US$ MN)
12.6. ASIA PACIFIC CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.7. ASIA PACIFIC CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.8. CHINA MARKET OVERVIEW
12.8.1. China Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
12.8.1.1. China Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.2. China Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
12.8.2.1. China Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.2.2. China Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.3. China Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
12.8.4. China Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.9. JAPAN MARKET OVERVIEW
12.9.1. Japan Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
12.9.1.1. Japan Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.9.2. Japan Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
12.9.2.1. Japan Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.9.2.2. Japan Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.9.3. Japan Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
12.9.4. Japan Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.10. INDIA MARKET OVERVIEW
12.10.1. India Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
12.10.1.1. India Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.10.2. India Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
12.10.2.1. India Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.10.2.2. India Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.10.3. India Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
12.10.4. India Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13. MIDDLE EAST AND AFRICA (MEA) CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. MIDDLE EAST & AFRICA (MEA) CANCER BIOMARKERS MARKET OVERVIEW
13.2. MIDDLE EAST & AFRICA (MEA) CANCER BIOMARKERS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. MIDDLE EAST & AFRICA (MEA) CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY BIOMARKER TYPE (US$ MN)
13.3.1. Middle East & Africa (MEA) Genetic Biomarkers Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.4. MIDDLE EAST & AFRICA (MEA) CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY PROFILING TECHNOLOGY (US$ MN)
13.4.1. Middle East & Africa (MEA) Omics Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.4.2. Middle East & Africa (MEA) Imaging Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.5. MIDDLE EAST & AFRICA (MEA) CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY CANCER TYPE (US$ MN)
13.6. MIDDLE EAST & AFRICA (MEA) CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.7. MIDDLE EAST & AFRICA (MEA) CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.8. SOUTH AFRICA MARKET OVERVIEW
13.8.1. South Africa Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
13.8.1.1. South Africa Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.8.2. South Africa Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
13.8.2.1. South Africa Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.8.2.2. South Africa Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.8.3. South Africa Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
13.8.4. South Africa Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
?
13.9. SAUDI ARABIA MARKET OVERVIEW
13.9.1. Saudi Arabia Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
13.9.1.1. Saudi Arabia Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.9.2. Saudi Arabia Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
13.9.2.1. Saudi Arabia Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.9.2.2. Saudi Arabia Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.9.3. Saudi Arabia Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
13.9.4. Saudi Arabia Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.10. UAE MARKET OVERVIEW
13.10.1. UAE Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
13.10.1.1. UAE Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.10.2. UAE Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
13.10.2.1. UAE Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.10.2.2. UAE Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.10.3. UAE Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
13.10.4. UAE Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
14. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
14.1. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET OVERVIEW
14.2. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
14.3. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY BIOMARKER TYPE (US$ MN)
14.3.1. South and Central America Genetic Biomarkers Market Revenue and Forecasts Analysis - By Type (US$ Mn)
14.4. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY PROFILING TECHNOLOGY (US$ MN)
14.4.1. South and Central America Omics Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
14.4.2. South and Central America Imaging Technologies Market Revenue and Forecasts Analysis - By Type (US$ Mn)
14.5. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY CANCER TYPE (US$ MN)
14.6. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
14.7. SOUTH AND CENTRAL AMERICA CANCER BIOMARKERS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
14.8. BRAZIL MARKET OVERVIEW
14.8.1. Brazil Cancer Biomarkers Market Revenue Forecasts and Analysis - By Biomarker Type (US$ Mn)
14.8.1.1. Brazil Genetic Biomarkers Market Revenue Forecasts and Analysis - By Type (US$ Mn)
14.8.2. Brazil Cancer Biomarkers Market Revenue Forecasts and Analysis - By Profiling Technology (US$ Mn)
14.8.2.1. Brazil Omics Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
14.8.2.2. Brazil Imaging Technologies Market Revenue Forecasts and Analysis - By Type (US$ Mn)
14.8.3. Brazil Cancer Biomarkers Market Revenue Forecasts and Analysis - By Cancer Type (US$ Mn)
14.8.4. Brazil Cancer Biomarkers Market Revenue Forecasts and Analysis - By Application (US$ Mn)
15. INDUSTRY LANDSCAPE
15.1. ORGANIC GROWTH STRATEGIES
15.1.1. New Product Launches
15.1.2. Marketing & Promotional Activities
15.2. INORGANIC GROWTH STRATEGIES
15.2.1. Partnerships, Collaborations, and Joint Ventures
15.2.2. Mergers & Acquisitions
?
16. CANCER BIOMARKERS MARKET, KEY COMPANY PROFILES
16.1. THERMO FISHER SCIENTIFIC INC.
16.1.1. Key Facts
16.1.2. Business Description
16.1.3. Financial Overview
16.1.4. Product Portfolio
16.1.5. SWOT Analysis
16.1.6. Key Developments
16.2. HOFFMANN-LA ROCHE LTD
16.2.1. Key Facts
16.2.2. Business Description
16.2.3. Financial Overview
16.2.4. Product Portfolio
16.2.5. SWOT Analysis
16.2.6. Key Developments
16.3. BIO-RAD LABORATORIES, INC.
16.3.1. Key Facts
16.3.2. Business Description
16.3.3. Financial Overview
16.3.4. Product Portfolio
16.3.5. SWOT Analysis
16.3.6. Key Developments
16.4. QIAGEN
16.4.1. Key Facts
16.4.2. Business Description
16.4.3. Financial Overview
16.4.4. Product Portfolio
16.4.5. SWOT Analysis
16.4.6. Key Developments
16.5. ILLUMINA, INC.
16.5.1. Key Facts
16.5.2. Business Description
16.5.3. Financial Overview
16.5.4. Product Portfolio
16.5.5. SWOT Analysis
16.5.6. Key Developments
16.6. GENERAL ELECTRIC COMPANY
16.6.1. Business Description
16.6.2. Financial Overview
16.6.3. Product Portfolio
16.6.4. SWOT Analysis
16.6.5. Key Developments
16.7. BIOMÉRIEUX, INC.
16.7.1. Key Facts
16.7.2. Business Description
16.7.3. Financial Overview
16.7.4. Product Portfolio
16.7.5. SWOT Analysis
16.7.6. Key Developments
16.8. CREATIVE DIAGNOSTICS
16.8.1. Key Facts
16.8.2. Business Description
16.8.3. Financial Overview
16.8.4. Product Portfolio
16.8.5. SWOT Analysis
16.8.6. Key Developments
16.9. HOLOGIC INC.
16.9.1. Key Facts
16.9.2. Business Description
16.9.3. Financial Overview
16.9.4. Product Portfolio
16.9.5. SWOT Analysis
16.9.6. Key Developments
16.10. QUEST DIAGNOSTICS
16.10.1. Key Facts
16.10.2. Business Description
16.10.3. Financial Overview
16.10.4. Product Portfolio
16.10.5. SWOT Analysis
16.10.6. Key Developments
17. APPENDIX
17.1. ABOUT THE INSIGHT PARTNERS
17.2. GLOSSARY OF TERMS
17.3. RESEARCH METHODOLOGY
The List of Companies
1. Thermo Fisher Scientific Inc.
2. F. Hoffmann-La Roche Ltd
3. Bio-Rad Laboratories, Inc.
4. QIAGEN
5. Illumina, Inc.
6. GENERAL ELECTRIC COMPANY
7. bioMérieux, Inc.
8. Creative Diagnostics
9. Hologic Inc.
10. Quest Diagnostics
1. Thermo Fisher Scientific Inc.
2. F. Hoffmann-La Roche Ltd
3. Bio-Rad Laboratories, Inc.
4. QIAGEN
5. Illumina, Inc.
6. GENERAL ELECTRIC COMPANY
7. bioMérieux, Inc.
8. Creative Diagnostics
9. Hologic Inc.
10. Quest Diagnostics